TrialCirculation2025

Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).

Yugo Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.